BENGALURU: Glenmark Pharmaceuticals Ltd on Tuesday said it would begin a clinical trial in India to test a combination of two antiviral drugs, favipiravir and umifenovir, as a potential COVID-19 treatment. Glenmark has secured Indian regulatory approval for the study, which will aim to enroll 158 inpatients with moderate COVID-19, the company said. Drug manufacturers …
BHUBANESWAR: Institute of Life Sciences (ILS), Bhubaneswar, an autonomous institute of the Department of Biotechnology under the Union Ministry of Science and Technology, has been identified for the establishment of biorepository for Covid-19 clinical trials. The center has identified 16 institutes in the country, including one in Bhubaneswar for this purpose. ILS Bhubaneswar official sources …
NEW DELHI: The center on Saturday asked the 11 municipal areas, accounting for 70% of active Covid-19 cases, to intensify early detection tests, timely clinical management and a reduction in deaths. The 11 areas of major litigation are in seven states – Maharashtra, Tamil Nadu, Gujarat, Delhi, Madhya Pradesh, West Bengal and Rajasthan. In a …
11 areas with 70% of cases asked to scale up Covid battle, Health News, ET HealthWorld Read More »
NEW DELHI: India reported 6,378 new Covid-19 infections on Saturday, the highest one-time jump in the case so far. This was the fifth summit in daily cases on so many days that took the country total coronavirus counts for just short of the 1.3 lakh mark, barely five days after the caseload crossed 1 lakh. …
New cases rise to 6,378; daily tax 144, Health News, ET HealthWorld Read More »
NEW DELHI: A revised advisory government has recommended the use of hydroxychloroquine as a preventive medicine for asymptomatic healthcare workers working in non-Covid-19 hospitals, front-line supervisory staff in containment zones and paramilitary / police personnel involved in coronavirus infection-related activities. As mentioned in the previous advice, the anti-infection drug is also recommended for all asymptomatic …
ICMR issues revised advice on hydroxychloroquine use, Health News, ET HealthWorld Read More »
As the number of coronavirus infection cases are proliferating in India (the number has now crossed 1.12,000 marks), a leading pharmaceutical giant, Stride Pharma made a breakthrough announcement stating that one of their drugs, Favipilavir, has received regulatory approvals and soon scientists will be kicked off clinical trials to the drug that is touted as …
(Representative image) NEW DELHI: The coronavirus deaths in Delhi have risen to 208, while 660 fresh cases of Covid-19 were reported on Friday, the biggest one-off spike here, authorities said. The total number of cases in the city now amounts to 12,319, they said. The previous highest increase in fresh cases 571 was recorded on …
New Delhi: Three drug trial to fight COVID-19 has started and seven are underway, Council of Scientific and Industrial Research (CSIR) Director General (DG) Dr Shekhar C Mande said on Thursday. “We have started three drug trials, namely ACQH, Favipiravir and MW. The MW trial has started very well in three different places. We are …
CSIR works on 10 different vaccines, drug trials, Health News, ET HealthWorld Read More »
PUNE: Public health Experts and epidemiologists have said community transmission of Covid-19 in certain pockets of Mumbai and Pune and in some places throughout the country it cannot be denied. The average cases per Million is 84 nationally, but parts of Maharashtra and Delhi have 4 to 7 times the national average, indicating such a …
New Delhi: Department of drugs (DoP) has suggested that the supervision of the Central Drugs Standard Control Organization (CDSCO) is transferred to it as the government is planning a major overhaul of the country drug authority. According to media reports, concerns have been raised at the highest levels of government over the regulatory framework’s ability …